Emerging evidence supported that patients harbouring a higher level of ANGPTL4 in various types of tumour were associated with poor prognosis after radiotherapy [37], and ANGPTL4 was expected to be an attractive prognostic or predictive biomarkers and a novel target for cancer treatment. The gene discussed is ANGPTL4; the disease is cancer.